

HY-158102 · Free Sample (0.1 - 0.2 mg)
MedChemExpress · Cat: HY-158102
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/oric-944.htmlDescription
Rinzimetostat ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 PRC2 . Rinzimetostat is synergistic with androgen receptor pathway inhibitors ARPIs for the study of metastatic prostate cancer.

